336 related articles for article (PubMed ID: 19554987)
1. Prevalence and predictors of white-coat hypertension in a large database of ambulatory blood pressure monitoring.
Abir-Khalil S; Zaîmi S; Tazi MA; Bendahmane S; Bensaoud O; Benomar M
East Mediterr Health J; 2009; 15(2):400-7. PubMed ID: 19554987
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between body-mass index and white-coat hypertension among referred patients.
Ben-Dov IZ; Mekler J; Ben-Arie L; Bursztyn M
Blood Press Monit; 2007 Apr; 12(2):95-9. PubMed ID: 17353652
[TBL] [Abstract][Full Text] [Related]
3. [Ambulatory blood pressure monitoring to study white coat syndrome in patients with hypertension seen in primary care].
Villalba Alcalá F; Lapetra Peralta J; Mayoral Sánchez E; Espino Montoro A; Cayuela Domínguez A; López Chozas JM
Rev Esp Cardiol; 2004 Jul; 57(7):652-60. PubMed ID: 15274850
[TBL] [Abstract][Full Text] [Related]
4. White coat hypertension in treated hypertensives: a three year follow-up study.
MacDonald MB; Laing GP; Wilson MP; Wilson TW
Can J Cardiovasc Nurs; 2003; 13(2):24-9. PubMed ID: 12802835
[TBL] [Abstract][Full Text] [Related]
5. Masked and white-coat hypertension in two cohorts of elderly subjects, ambulatory and hospitalized patients.
Giantin V; Franchin A; Toffanello ED; Simonato M; Baccaglini K; Grosso G; Maselli M; Enzi G; Manzato E
Arch Gerontol Geriatr; 2009; 49 Suppl 1():125-8. PubMed ID: 19836625
[TBL] [Abstract][Full Text] [Related]
6. The use of ambulatory blood pressure monitoring in managing hypertension according to different treatment guidelines.
Addison C; Varney S; Coats A
J Hum Hypertens; 2001 Aug; 15(8):535-8. PubMed ID: 11494091
[TBL] [Abstract][Full Text] [Related]
7. The natural history of white coat hypertension during pregnancy.
Brown MA; Mangos G; Davis G; Homer C
BJOG; 2005 May; 112(5):601-6. PubMed ID: 15842284
[TBL] [Abstract][Full Text] [Related]
8. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension.
Tomiyama M; Horio T; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
J Hum Hypertens; 2007 Mar; 21(3):212-9. PubMed ID: 17167525
[TBL] [Abstract][Full Text] [Related]
9. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study.
Gustavsen PH; Høegholm A; Bang LE; Kristensen KS
J Hum Hypertens; 2003 Dec; 17(12):811-7. PubMed ID: 14704724
[TBL] [Abstract][Full Text] [Related]
10. True resistant hypertension: is it possible to be recognized in the office?
Muxfeldt ES; Bloch KV; Nogueira Ada R; Salles GF
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1534-40. PubMed ID: 16364821
[TBL] [Abstract][Full Text] [Related]
11. White coat hypertension in Zimbabwean African women.
Bhagat K
East Afr Med J; 2000 Aug; 77(8):452-5. PubMed ID: 12862073
[TBL] [Abstract][Full Text] [Related]
12. Comparison between continuous ambulatory arterial blood pressure monitoring and standard blood pressure measurements among patients of younger and older age group.
Babić BK; Bagatin J; Kokić S; Ostojić SB; Carević V; Berović N
Coll Antropol; 2009 Mar; 33(1):65-70. PubMed ID: 19408605
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of the white-coat effect at multiple visits before and during treatment.
Verberk WJ; Kroon AA; Thien T; Lenders JW; van Montfrans GA; Smit AJ; de Leeuw PW
J Hypertens; 2006 Dec; 24(12):2357-63. PubMed ID: 17082716
[TBL] [Abstract][Full Text] [Related]
14. Ambulatory blood pressure measurement in the main cities of Cameroon: prevalence of masked and white coat hypertension, and influence of body mass index.
Takah N; Dzudie A; Ndjebet J; Wawo G; Kamdem F; Monkam Y; Luma H; Ngu KB; Kengne AP
Pan Afr Med J; 2014; 19():240. PubMed ID: 25848455
[TBL] [Abstract][Full Text] [Related]
15. White coat effect and white coat hypertension in pediatric patients.
Matsuoka S; Kawamura K; Honda M; Awazu M
Pediatr Nephrol; 2002 Nov; 17(11):950-3. PubMed ID: 12432440
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of white coat hypertension in primary health care.
Alves LM; Nogueira MS; Godoy Sd; Hayashida M; Cárnio EC
Arq Bras Cardiol; 2007 Jul; 89(1):28-35. PubMed ID: 17768580
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical correlates of white coat hypertension in chronic kidney disease.
Minutolo R; Borrelli S; Scigliano R; Bellizzi V; Chiodini P; Cianciaruso B; Nappi F; Zamboli P; Conte G; De Nicola L
Nephrol Dial Transplant; 2007 Aug; 22(8):2217-23. PubMed ID: 17420167
[TBL] [Abstract][Full Text] [Related]
18. Predictors for the white coat effect in general practice patients with suspected and treated hypertension.
Lindbaek M; Sandvik E; Liodden K; Mjell J; Ravnsborg-Gjertsen K
Br J Gen Pract; 2003 Oct; 53(495):790-3. PubMed ID: 14601355
[TBL] [Abstract][Full Text] [Related]
19. White coat hypertension in adolescents.
Koch VH; Furusawa EA; Saito MI; Colli A; Ignes EC; Okay Y; Mion Júnior D
Clin Nephrol; 1999 Nov; 52(5):297-303. PubMed ID: 10584993
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing white-coat effect.
Manios ED; Koroboki EA; Tsivgoulis GK; Spengos KM; Spiliopoulou IK; Brodie FG; Vemmos KN; Zakopoulos NA
Am J Hypertens; 2008 Feb; 21(2):153-8. PubMed ID: 18174883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
